Testing effectiveness (Phase 2)Not Yet RecruitingNCT07229872
What this trial is testing
A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in the Treatment of Immunodominant pMMR/MSS Metastatic Colorectal Cancer That Has Failed Second-line or Above Treatment
Who this might be right for
Colorectal Cancer
Harbin Medical University 18